Viatris Receives U.S. FDA Approval for RYZUMVI for the Treatment of Presbyopia
Viatris Receives U.S. FDA Approval for RYZUMVI for the Treatment of Presbyopia Viatris Receives U.S. FDA Approval for RYZUMVI for the Treatment of PresbyopiaPR NewswirePITTSBURGH, Oct. 16, 2026 PITTSBURGH, Oct. 16, 2026 /PRNewswire/ -- Viatris Inc.(Nasdaq: VTRS), a global healthcare company, today...